Cheol-Kyu Park

Dr. Cheol-Kyu Park

Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Immune Network
Verified
Journal Article
Open access
PDF file
DKDa Hyun Kang
Da Hyun Kang
Cheol-Kyu ParkCheol-Kyu Park
Cheol-Kyu Park
CCChaeuk Chung
Chaeuk Chung
In-Jae OhIn-Jae Oh
In-Jae Oh
YKYoung-Chul Kim
Young-Chul Kim
JLJeong Eun Lee
Jeong Eun Lee
Kang DH, et al. Immune Netw. 2020 May;20(3):e27. https://doi.org/10.4110/in.2020.20.e27

1 June 2008 in Biochemical Pharmacology
Verified
Journal Article
Closed access
Cheol-Kyu ParkCheol-Kyu Park
Cheol-Kyu Park
YLYoungkyun Lee
Youngkyun Lee
ECEun-Ju Chang
Eun-Ju Chang
MLMing Hong Lee
Ming Hong Lee
JYJeong Hoon Yoon
Jeong Hoon Yoon
HKHong-Hee Kim
Hong-Hee Kim

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
Cheol-Kyu ParkCheol-Kyu Park
Cheol-Kyu Park
HSHong-Joon Shin
Hong-Joon Shin
YKYu-Il Kim
Yu-Il Kim
SLSung-Chul Lim
Sung-Chul Lim
JYJeong-Sun Yoon
Jeong-Sun Yoon
YKYong-Soo Kwon
Yong-Soo Kwon
Park CK, et al. J Korean Med Sci. 2016 Feb;31(2):254-260. http://dx.doi.org/10.3346/jkms.2016.31.2.254

1 September 2018 in Clinical Lung Cancer
Verified
Journal Article
Closed access
In-Jae OhIn-Jae Oh
In-Jae Oh
JHJae Young Hur
Jae Young Hur
Cheol-Kyu ParkCheol-Kyu Park
Cheol-Kyu Park
YKYoung-Chul Kim
Young-Chul Kim
SKSeung Joon Kim
Seung Joon Kim
CCChang-Min Choi
Chang-Min Choi

1 January 2017 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
HSHong-Joon Shin
Hong-Joon Shin
JCJin-Sun Chang
Jin-Sun Chang
SASeong Ahn
Seong Ahn
TKTae-Ok Kim
Tae-Ok Kim
Cheol-Kyu ParkCheol-Kyu Park
Cheol-Kyu Park
YKYong-Soo Kwon
Yong-Soo Kwon
Background: For patients requiring prolonged mechanical ventilation (PMV), weaning is difficult and mortality is very high. PMV has been defined recently, by consensus, as constituting ≥21 consecutive days of mechanical ventilation (MV) for ≥6 hours per day. This study aimed to evaluate the clinical factors predicting weaning failure in patients undergoing PMV in medical intensive care unit (ICU). Methods: We retrospectively reviewed the clinical and laboratory characteristics of 127 patients who received MV for more than 21 days in the medical ICU at Chonnam National University Hospital in South Korea between January 2005 and December 2014. Patients who underwent surgery or experienced trauma were excluded from this study. Results: Among the 127 patients requiring PMV, 41 (32.3%) were successfully weaned from MV. The median age of the weaning failure group was higher than that of the weaning success group (74.0 vs. 70.0 years; P=0.003). The proportion of male patients was 58.5% in the weaning success group and 72.1% in the weaning failure group, respectively. The most common reasons for ICU admission were respiratory causes (66.1%) followed by cardiovascular causes (16.5%) in both groups. ICU mortality and in-hospital mortality rates were 55.1% and 55.9%, respectively. In the multivariate analysis, respiratory causes of ICU admission [odds ratio (OR), 3.98; 95% confidence interval (CI), 1.29–12.30; P=0.016] and a high sequential organ failure assessment (SOFA) score on day 21 of MV (OR, 1.47; 95% CI, 1.17–1.85; P=0.001) were significantly associated with weaning failure in patients requiring PMV. The area under the receiver operating characteristic (ROC) curve of the SOFA score on day 21 of MV for predicting weaning failure was 0.77 (95% CI, 0.67–0.87; P=0.000). Conclusions: Respiratory causes of ICU admission and a high SOFA score on day 21 of MV could be predictive of weaning failure in patients requiring PMV.

29 December 2014 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
WKWoo‐Jin Kim
Woo‐Jin Kim
SKSunmin Kim
Sunmin Kim
HCHayoung Choi
Hayoung Choi
JCJinsun Chang
Jinsun Chang
HSHong‐Joon Shin
Hong‐Joon Shin
YCYoo‐Duk Choi
Yoo‐Duk Choi
Several cases of acquired resistance in patients with activating epidermal growth factor receptor (EGFR) mutation have been reported. However, rare clinical cases exist of a transformation to small cell lung cancer (SCLC) following treatment with EGFR‐tyrosine kinase inhibitors (TKIs). We report a case of non‐small cell lung cancer (NSCLC) with L858R mutation at the time of diagnosis. After failure of EGFR‐TKI therapy, we performed additional histopathologic examinations. We confirmed that the patient had a histological transformation from NSCLC to SCLC. We performed chemotherapy with etoposide and cisplatin against the SCLC and radiologic findings were improved.